These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 10081120)

  • 1. Reduction of cardiovascular mortality in type-2 diabetes by aggressive and early intervention strategies.
    Schernthaner G
    Wien Klin Wochenschr; 1999 Jan; 111(2):43-5. PubMed ID: 10081120
    [No Abstract]   [Full Text] [Related]  

  • 2. Diabetes, fitness, and body mass index.
    Johnson ST; Eurich DT; Johnson JA
    Arch Intern Med; 2006 Jun; 166(12):1326-7; author reply 1327. PubMed ID: 16801523
    [No Abstract]   [Full Text] [Related]  

  • 3. Diabetes and cardiovascular risk equivalency: do age at diagnosis and disease duration affect risk stratification?: comment on "impact of diabetes on cardiovascular disease risk and all-cause mortality in older men".
    Idris I
    Arch Intern Med; 2011 Mar; 171(5):410-1. PubMed ID: 21403037
    [No Abstract]   [Full Text] [Related]  

  • 4. [Management of diabetes in cardiac diseases].
    Işik S; Delibaşi T; Berker D; Aydin Y; Güler S
    Anadolu Kardiyol Derg; 2009 Jun; 9(3):238-47. PubMed ID: 19520659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular risk and cardiometabolic protection: role of glitazones.
    Petrazzi L; Grassi D; Polidoro L; D'Aurelio A; Croce G; Properzi G; Tiberti S; Desideri G; Ferri C
    J Nephrol; 2008; 21(6):826-35. PubMed ID: 19034866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular risk factors as predictors of mortality in type II diabetic patients.
    Mudríková T; Gmitrov J; Tkác I; Gonsorcík J; Szakács M
    Wien Klin Wochenschr; 1999 Jan; 111(2):66-9. PubMed ID: 10081124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. All-cause mortality risk predictors in a preventive cardiology clinic cohort-examining diabetes and individual metabolic syndrome criteria: a PRECIS database study.
    Doshi KB; Kashyap SR; Brennan DM; Hoar BM; Cho L; Hoogwerf BJ
    Diabetes Obes Metab; 2009 Feb; 11(2):102-8. PubMed ID: 18494803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Post-challenge hyperglycaemia is associated with premature death and macrovascular complications.
    Qiao Q; Tuomilehto J; Borch-Johnsen K
    Diabetologia; 2003 Mar; 46 Suppl 1():M17-21. PubMed ID: 12652354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Mortality from cardiovascular diseases in patients with type 2 diabetes].
    Janeczko D; Kopczyński J; Lewandowski Z; Janeczko-Sosnowska E; Tuszyńska A
    Przegl Lek; 2000; 57 Suppl 4():3-7. PubMed ID: 11293227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subclinical hypothyroidism is associated with reduced all-cause mortality in patients with type 2 diabetes.
    Sathyapalan T; Manuchehri AM; Rigby AS; Atkin SL
    Diabetes Care; 2010 Mar; 33(3):e37. PubMed ID: 20190285
    [No Abstract]   [Full Text] [Related]  

  • 11. Early screening for diabetes mellitus: has it been overstated?
    Boucher FG
    Can Fam Physician; 2004 Nov; 50():1503-4. PubMed ID: 15597968
    [No Abstract]   [Full Text] [Related]  

  • 12. [Diabetes Infobus 1999. Blood pressure].
    Ecker J
    Acta Med Austriaca Suppl; 2002; 56():12-3. PubMed ID: 12436706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ["Evaluation report of Diabetes Action Infobus 1999 of the Austrian Diabetes Society"].
    Irsigler K
    Acta Med Austriaca Suppl; 2002; 56():1-2. PubMed ID: 12436702
    [No Abstract]   [Full Text] [Related]  

  • 14. Strategies to improve diabetes care.
    Bodenheimer T
    Am Fam Physician; 2003 Oct; 68(8):1500, 1503-4, 1506. PubMed ID: 14596438
    [No Abstract]   [Full Text] [Related]  

  • 15. [Nephropathy and metabolic heart diseases. Cardiac risk in kidney malfunction].
    MMW Fortschr Med; 2012 Aug; 154(14):70-1. PubMed ID: 22957461
    [No Abstract]   [Full Text] [Related]  

  • 16. Body mass index and the risk of total and cardiovascular mortality among patients with type 2 diabetes: a large prospective study in Ukraine.
    Khalangot M; Tronko M; Kravchenko V; Kulchinska J; Hu G
    Heart; 2009 Mar; 95(6):454-60. PubMed ID: 18697804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effects of thiazolidinediones on dyslipidemia in patients with type 2 diabetes. Are all equally vasoprotective?].
    Haberbosch W
    Herz; 2007 Feb; 32(1):51-7. PubMed ID: 17323035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Insulin resistance increases risk of infarct. Glitazone now approved also for monotherapy].
    MMW Fortschr Med; 2003 Sep; 145(38):61. PubMed ID: 14603688
    [No Abstract]   [Full Text] [Related]  

  • 19. [Results of ADVANCE trial conducted in type 2 diabetic patients].
    Ter Arkh; 2008; 80(1):88. PubMed ID: 18326237
    [No Abstract]   [Full Text] [Related]  

  • 20. The joint effects of different types of glucose-lowering treatment and duration of diabetes on total and cardiovascular mortality among subjects with type 2 diabetes.
    Khalangot M; Tronko M; Kravchenko V; Kulchinska J; Hu G
    Diabetes Res Clin Pract; 2008 Oct; 82(1):139-47. PubMed ID: 18703252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.